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Abbreviations 
 
Ac acetyl 
anhyd. anhydrous 
aq. aqueous or water solution 
Ar aryl  
atm. atmosphere 
β-ICD β-isocupreidine 
BINOL 1,1’-bi-2, 2’-naphthol 
Bn benzyl 
Boc tert-butoxycarbonyl 
Bz benzoyl 
cat. catalyst or catalytic amount of 
COSY correlation spectroscopy 
CPME cyclopentylmethyl ether 
cHex or Cy cyclohexyl 
d days 
DABCO 1,4-diazabicyclo[2.2.2]octane 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DCM dichloromethane 
DEA diethylamine 
DIBAL diisobutylaluminium hydride 
DMAP 4-(dimethylamino)pyridine 
DMP Dess-Martin periodinane 
dr diastereomeric ratio 
E entgegen 
EDG electron donating group 
ee enantiomeric excess 
eq equivalent 
ESI-MS electrospray ionization mass spectrometry 
Et ethyl 
EVK ethyl vinyl ketone 
EWG electron withdrawing group 
Fc ferrocenyl 
FMO frontier molecular orbital 
FG functional group 
Fig. figure 
FT-IR Fourier transform infrared spectroscopy 
GPC gel permeation chromatography 
h hour 
HFIPA 1,1,1,3,3,3-hexafluoroisopropyl acryl ester 
HMBC heteronuclear multiple bond correlation 
HMQC heteronuclear multiple quantum correlation 
HOMO highest occupied molecular orbital 
HPLC high performance liquid chromatography 
IBX 2-iodoxybenzoic acid 
INADEQUATE incredible natural abundance double quantum transfer experiment 
INEPT insensitive nuclei enhanced by polarization transfer 
IPA isopropyl alcohol 
J coupling constant 
KHMDS potassium hexamethyldisilazide 
LA Lewis acid 
LAH lithium aluminium hydride 
LB Lewis base 
LDA lithium diisopropylamide 
LHMDS lithium hexamethyldisilazide 
liq. liquid 
LUMO lowest unoccupied molecular orbital 
MBH Morita-Baylis-Hillman 
Me methyl 
Mes mesityl (2,4,6-trimethylphenyl) 
min minute 
MO molecular orbital 
MOM methoxymethyl 
m.p. melting point 
Ms mesyl (methanesulfonyl) 
MS molecular sieve 
MTBE methyl tert-butyl ether 
MVK methyl vinyl ketone 
M.W. molecular weight 
µW microwave 
NBS N-bromosuccinimide 
NCS N-chlorosuccinimide 
NIS N-iodosuccinimide 
NMR nuclear magnetic resonance 
NOE nuclear Overhauser effect 
NOESY nuclear Overhauser effect spectroscopy 
Np naphthyl 
NR or n.r. no reaction 
Ns nosyl (nitrosobenzenesulfonyl) 
Nu or Nuc nucleophile 
ORTEP Oak Ridge Thermal Ellipsoid Program 
PG protecting group 
Ph phenyl 
Ph-H benzene 
Piv pivaloyl 
PMP para-methoxyphenyl 
PPA polyphosphoric acid 
ppm parts per million 
iPr isopropyl 
Proton-sponge 1,8-Bis(dimethylamino)naphthalene 
P.T. proton transfer 
PTC phase-transfer-catalyst 
PTSA p-toluenesulfonic acid 
Py pyridine 
quant. quantitative 
R alkyl 
R rectus 
rac racemic 
RCM ring-closing metathesis 
RDS rate-determining step 
Rf perfluoroalkyl group 
Rf retention factor in chromatography 
Rochelle salt potassium sodium tartrate 
ROESY rotating frame nuclear Overhauser effect spectroscopy 
ROM ring-opening metathesis 
rt room temperature 
S sinister 
s seconds 
SET single electron transfer 
(R)-SITCP (11aR)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef] 
phosphine 
SOMO single occupied molecular orbital 
SPRIX spiro bis(isoxazoline) 
TBAB tetrabutylammonium bromide 
TBS tert-butyldimethylsilyl 
TBHP tert-butylhydroperoxide 
TEA triethylamine 
TEMPO 2,2,6,6-tetramethylpiperidinyloxy 
temp. temperature 
Tf trifluoromethanesulfonyl 
TFA trifluoroacetic acid 
TFAA trifluoroacetic anhydride 
THF tetrahydrofuran 
TLC thin layer chromatography 
TMEDA N,N,N’,N’-tetramethylethylenediamine 
TMG 1,1,3,3-tetramethylguanidine 
TMS tetramethylsilyl or tetramethylsilane 
Ts para-toluenesulfonyl 
TS transition state 
UV ultraviolet 
vic vicinal 
Weinreb amide N,O-dimethylhydroxamic acids 
XRD x-ray diffraction 
xyl or xylyl 3,5-dimethylphenyl 
y. yield 
Z benzyloxycarbonyl 
Z zusammen 
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Chapter 1  
Background 
 
 Synthesis of enantiopure compounds represents one of the most attractive and 
challenging fields in organic synthesis.[1] Complementary to the traditional metal-mediated 
asymmetric synthesis,[2] and inspired by the enzymatic labor in Nature, the use of simple and 
small organic compounds as catalyst has gained more and more applications in current 
organic synthesis.[3] Coined and defined in 2000 by W. C. MacMillan,[4] organocatalysis has 
had a fast developing owing to their in general important advantages such as: non-toxic, 
usually stable under aerobic conditions, commercially available or easy synthesized, reactions 
conducted under mild conditions, among others.[3] 
 
Scheme 1.- Pioneering example of organocatalysis promoted by (S)-proline. 
 
Historically, the discovery of organocatalysis can be dated to the late of 1950s with 
the report of Pracejus on the preparation of (-)-α-phenyl methylpropionate in 74% ee by using 
an alkaloid-type tertiary amine.[5] However, high yield and high enantioselectivity was first 
observed on the (S)-proline promoted Robinson annulation, up to 93% ee, thereby considered 
one of the frameworks of organocatalysis (Scheme 1).[6] The process involving aldol reaction 
and known as Hajos-Parris-Eder-Sauer-Wiechert reaction provides access to some key 
intermediates for the synthesis of natural products. Identified as potential versatile catalyst, in 
2000 List and Barbas applied (S)-proline on the aldol reaction achieving results comparable 
in terms of enantioselectivities to those obtained by using metal-containing catalyst (Scheme 
2).[7]   
 
   
 
 
 
Scheme 2.- Asymmetric aldol reaction catalyzed by (S)-proline. 
2 
 
Scheme 3.- Asymmetric Diels-Alder cycloaddition catalyzed by imidazolidinone catalyst. 
 
 MacMillan reported secondary amine catalyst to activate enals via iminium ion for 
the synthesis cyclohexenyl ring systems by Diels-Alder reaction with notably 
enantioselectivity levels (Scheme 3).[4] Thus, the concept of iminium ion activation together 
with the proline aldol research described by List and Barbas set the bases for the emerging 
organocatalysis generation.  
 
 Figure 1.- General classification of the activation mode in organocatalysis. 
 
 The fast development of organocatalysis has allowed it to be recognized as an 
independent synthetic area. The organocatalysts have two main functions; they can activate 
the electrophile or the nucleophile (or both in the case of bifunctional catalysis), or they 
create an asymmetric environment that is responsible for setting the chirality of the product. 
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Based on the interaction or activation, organocatalysts can be classified into two big groups 
as covalent or non-covalent catalysts (Figure 1). In covalent catalysis, a covalent bond 
between the organocatalyst and the substrate is formed. In this category, aminocatalysis[8] and 
carbenes[9] are included. In the case of non-covalent interactions between the substrate and 
the catalyst, the activation of the substrate occurs via hydrogen bonds[10] (e.g., thioureas,[11] 
squaramides[12] and phosphoric acids[13]) or ionic interactions (e.g., chiral bases such as 
cinchona alkaloids[14] and phase-transfer-catalysts[15]).  
 
 
Catalytic formation of tetrasubstituted carbon stereogenic centers 
 
 Preparation of enantiopure compounds bearing a tertiary stereogenic center in 
academia and industry has reached very good levels by applying the large variety of available 
methods including chiral auxiliaries, ligands or catalysis.[16] However, synthesis of 
biologically relevant molecules bearing a tetrasubstituted stereogenic center still remains as 
challenging field.[17]    
 
 
Scheme 4.- Asymmetric addition of TMSCN to ketimines. 
 
 The straightforward method to create tetrasubstituted carbon centers is through the 
nucleophilic addition. Several groups were involved on the addition of silyl enolates to 
ketones where a chelating ketone was coordinate to different metal complexes to yield high 
levels of stereoselectivity.[18] Similarly, it was envisioned the synthesis of amines on a 
tetrasubstituted carbon center by the corresponding nucleophilic addition to ketimines. The 
Strecker reaction represents an important transformation which provides access to 
α-disubstituted amino acids derivatives. Vallée reported the first examples of metal-catalyzed 
asymmetric additions of TMSCN or HCN catalyzed by titanium-based complexes, and more 
successfully with chiral heterobimetallic scandium complex (Scheme 4).[19] In a subsequent 
series of publications Shibasaki described the use of gadolinium complexes affording high 
enantioselectivities, up to 98% ee.[20]  
4 
This work 
 
 
Scheme 5.- Enantioselective synthesis of relevant structures bearing a 
tetrasubstituted stereogenic carbon center. 
 
 
 
Although generation of compounds bearing a tetrasubstituted carbon center has been 
partially developed by using metallic-complexes,[17-21] there is great concern about the use of 
metal-containing catalyst, especially for the synthesis of compounds with potential 
application in the pharmaceutical industry. In this work, I have developed a series of 
strategies involving organocatalysis for the synthesis of several important compounds 
possessing a chiral tetrasubstituted carbon center in high enantioselectivities (Scheme 5).  
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Chapter 2 
 Aza-Morita-Baylis-Hillman (aza-MBH) reaction of ketimines 
 
 The Morita-Baylis-Hillman (MBH) reaction is known to be one of the most efficient 
C-C bond forming reactions between electron-deficient alkenes with aldehydes, allowing 
access to highly functionalized allylic alcohols with atom economy in straightforward 
manner.[1] The reaction was first reported in 1968 by Morita and co-workers (Scheme 1a).[2]  
 
   
 
 
 
 
 
 
Scheme 1.- Morita-Baylis-Hillman (MBH) reaction. 
 
Unfortunately, this phosphine-promoted transformation suffered from low yields and it was 
neglected for a while. In 1972 a German patent indicating similar transformation under 
tertiary amine catalysis was reported (Scheme 1b).[3] Owing to its synthetic importance, 
several groups were involved on the study of the reaction mechanism and the development of 
different methods to expand the scope of MBH reaction by using metal and metal-free 
protocols.[1] Among these, the introduction of β-ICD (β-isocupreidine) by Hatakeyama and 
Iwabuchi represented an important step through the development of asymmetric MBH 
reaction. They reported the addition of acrylates to a variety of aromatic and aliphatic 
aldehydes  for the formation of  MBH-adducts up to 99% ee (Scheme 2).[4] The use of that  
 
Scheme 2.- Asymmetric MBH reaction of aldehydes and HFIPA catalyzed by β-ICD. 
1
2
1
2
3
7 
 
Scheme 3.- Asymmetric aza-MBH reaction catalyzed by β-ICD 
 
particular substrate 1,1,1,3,3,3-hexafluoroisopropyl acryl ester (HFIPA) displayed an almost 
200-fold rate acceleration compared to methyl acrylate, under identical reaction conditions. 
The same organocatalyst showed high activity on the corresponding reaction of enone 4 and 
imine 5, aza-MBH reaction, for the enantioselective synthesis of allylic amines as reported by 
Shi in 2002 (Scheme 3).[5]  
 
Scheme 4.- Chiral bifuctional organocatalyst for aza-MBH reaction. 
 
 As demonstrated by our group and others,[6] BINOL and SPINOL-based bifunctional 
chiral organocatalysts (phosphines or tertiary amines) among other systems, have been found 
to work exceptionally well on the aza-MBH reaction of aldimines (Scheme 4). The general 
accepted mechanism is illustrated in Scheme 5.[1,4-7] Michael addition of chiral Lewis base 
(LB) organocatalyst generates the formation of an enolate intermediate A. Using a brønsted 
acid  would help to  enhance the stability of  this intermediate through hydrogen bonding  
8 
 
 
 
Scheme 5.- Reaction mechanism of aza-MBH reaction. 
 
donation. The second step involves the aldol type addition to the electrophile, in this case 
aldimine, generating thus a new C-C bond (intermediate B). This is also the 
enantioselectivity- determining step. As described on the intermediate B, complexity on the 
enantioselective discrimination arises from the fact that two different possible diastereomeric 
intermediates can be generated. To avoid steric interactions, catalyst would prefer to 
approach via the less congested face of the substrate, locating the bulky group far from the 
approaching site. The next step is a proton transfer to generate C. Finally, a retro-Michael 
step delivers the enantioenriched aza-MBH adduct with concurrent regeneration of the 
organocatalyst to complete the catalytic cycle. It is clear that in the case of one of the 
substituents on aldimine is an aryl group and the other hydrogen, the transition state generally 
favors location of aryl group far from the catalyst backbone decreasing steric hindrance, 
thereby increasing the possibility to obtain higher enantioselectivity.  
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  Scheme 6.- Achiral aza-MBH reaction of ketimines. 
 
 Although several examples on the enantioselective aza-MBH reaction of aldimines 
are reported in literature,[1,4-7] the corresponding process using ketimines as substrates (where 
hydrogen in imine is replaced for a different substituent), which eventually would provide 
access to a multifuctional allylic amines bearing a tetrasubstituted carbon center, remained 
undisclosed. The only example found in literature was reported in 2001 by Burger.[8] A very 
activated bis-trifluoromethyl ketimine was reacted with acrylate in presence of a 
stoichiometric amount of DABCO delivering aza-MBH adduct in moderate yield (Scheme 6).    
 
Table 1.- Achiral LB catalyzed aza-MBH reaction of 11a with 12. 
 
 
 
 
Entry Lewis base PG Solvent Yield % 
1 DMAP Ts DCM 10 
2 DABCO Ts DCM 7 
3 DBU Ts DCM trace 
 
4 
 
 
Ts 
 
DCM 
 
trace 
5 PPh3 Ts DCM 74 
6 PPh3 Ts (CH2Cl)2 70 
7 PPh3 Ts CHCl3 54 
8 PPh3 Ts toluene 80 
9 PPh3 Ts THF 34 
10 PPh3 Ts Et2O 50 
11 PPh3 Ts MTBE 96 
12 PPh3 PMP MTBE NR 
Conditions: 11a (0.12 mmol), 12 (0.04 mmol), LB (10 mol%). PG = Protecting group. NR = No reaction. 
2
2
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With the aim of developing a method for construction of α,α-disubstituted amino acid 
derivatives bearing a chiral tetrasubstituted carbon center, ester-containing ketimine was 
selected as a model substrate. The reaction was initially explored with achiral Lewis bases 
(Table 1). Amine type catalyst such as DABCO and DMAP provided poor yields of the 
aza-MBH adduct accompanied with decomposition of ketimine (entries 1,2). Trace amount of 
 
  Table 2.- Enantioselective aza-MBH reaction of 11a with ketimine 12a.  
 
 
 
 
Entry Chiral organocatalyst Yield % ee % 
1 (R)-(S)-PPFA trace -- 
2 β-ICD trace -- 
3 (S)-BINAP trace -- 
4 (R)-MeO-MOP, (R)-7 trace -- 
5 (R)-14 29 0 
6 (S)-8, (S)-10 trace -- 
7 (S)-9 25 38 
8 (S)-15a 87 96 
9 (S)-15b 70 89 
10 (S)-15c 42 15 
11 (S)-15d 52 17 
12 (S)-15e trace -- 
Conditions: 11a (0.12 mmol), 12a (0.04 mmol), chiral organocatalyst (10 mol%). 
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11 
product was observed by using DBU or 2-phenyl-2-imidazolidine (entries 3,4). Gratifyingly, 
the reaction proceeded smoothly under PPh3 catalysis, affording the racemic α,α-disubstituted 
amino acid derivative in 74% yield (entry 5). Further screening improved the yield up to 96% 
chemical yield by using t-BuOMe (MTBE) as solvent (entry 11). No reaction was observed 
when PMP was used as protecting group (entry 12). 
 
Next, various chiral catalysts such as (R)-(S)-PPFA, β-ICD, (S)-BINAP, 
(R)-MeO-MOP, and compounds (R)-7, (S)-8-10, were tested as shown in Table 2. Some of 
them, which are known to mediate the enantioselective MBH-type processes.[1,4-7,9] showed 
no activity with ketimine 12a (entries 1-4, 6). Chiral organocatalyst (R)-14 possessing highly 
nucleophilic phosphine led to racemic product (entry 5). The acid-base organocatalyst 
(S)-9[6f] promoted the reaction to give 13a in 25% yield and 38% ee (entry 7). During the 
screening process, P-chirogenic[10] organocatalysts were found to promote the aza-MBH  
reaction.  Thus, the ferrocenyl P-chirogenic organocatalyst (S)-15a promoted the reaction in  
 
2
[a],[c]
[b],[c]
2
[a],[d]
2
[a],[c]
2
[a]
[b]
2
[a]
[b]
2 2 3
[a]
2
[a]
2
[a] (S)-15a was used. [b] (S)-15b was used. [c] Performed at 10 °C. [d] 20 mol% was used. NR = No reaction. 
Scheme 7.- Substrate scope catalyzed by P-chirogenic organocatalyst. 
12 
87% yield with 96% ee (entry 8), whereas (S)-15c with methyl and (S)-15d with 
methoxymethyl as ortho-substituents exhibited low asymmetric inductions (entries 10, 11). 
No catalytic activity was observed when (S)-15e bearing an ortho-hydroxy substituent was 
used (entry 12). Since the organocatalyst (S)-15b having an ethyl substituent afforded 13a 
with high enantioselectivity (entry 9), the steric effect of the hydroxymethyl group or the 
ethyl substituent on the catalyst (S)-15a and (S)-15b respectively, would be important to 
promote the reaction with high enantiocontrol.  
 
 With the optimized conditions, substrate scope was studied (Scheme 7). Moderate to 
high enantioselectivities were obtained irrespective of the electronic nature of the substituent 
on the aromatic ring (entries 13a to 13e). Replacing ethyl ester for trifluoroethyl ester 
delivered the aza-MBH adduct in higher enantioselectivity, 97% ee (entry 13f). The reaction 
was not restricted to MVK (methyl vinyl ketone), but also ethyl group was successfully 
introduced (entry 13g). However, the reaction was sensitive to sterically demanding 
ortho-substituted substrates, resulting in no reaction (entry 13h). 
 
Scheme 8.- aza-MBH reaction of isatin-derived ketimine 16. 
 
 Cyclic isatin-derived ketimine was also found to be suitable substrate, affording the 
desired product 17 in 90% ee (Scheme 8). Applying catalyst (S)-15a and (S)-15b to 
α,β-unsaturated ketimine 18 delivers the desired aza-MBH product in low yield and moderate 
enantioselectivities, along with the formation of tetrahydropyridne 20,[11] generated through a  
 
[a] (S)-15a was used. [b] (S)-15b was used. 
Scheme 9.- aza-MBH reaction of α,β-unsaturated ketimine 18 using (S)-15a-b. 
13 
[a] (RP,R)-15f was used. [b] (RP,S)-15f was used. 
Scheme 10.- aza-MBH reaction of α,β-unsaturated ketimine 18 using catalyst 15f. 
 
[4+2] cyclization process (Scheme 9). The reaction was then explored with more bulky 
catalysts. Using P-chirogenic organocatalysts (Rp,R)-15f and (Rp,S)-15f were found to give 
the aza-MBH adduct 19 in moderate yield and moderate enantioselectivities (Scheme 10).  
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Scheme 11.- Synthetic transformations of aza-MBH adducts 13. 
 
14 
 To demonstrate the synthetic utility of highly functionalized aza-MBH products 13, 
a variety of transformations were performed (Scheme 11). The α-methyl ketone 21 was 
obtained in good yield by 1,4-conjugated reduction of 13a using Pd/C under H2 without over 
reduction. Amino acid derivative 22 can be easily obtained after 2 steps, reduction and 
hydrolysis, accompanied by a five-membered ring byproduct 23, starting from 13a. 
Furthermore, Michael addition of BuLi with CuI or diethylmalonate with K2CO3 to 13d 
produced the cyclic products 24 and 25 via sequential 1,4-addition/lactonization with over 
85% yields, respectively.  
 
 
 
 
 
Note: 
 By the same time of the report of our research, and independently, the groups of 
Shi and Chen have reported enantioselective aza-MBH reaction of ketimines using 
different catalysts and different substrates to those described here.[12] 
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Chapter 3 
 Formal [2+2] cycloaddition reaction of ketimines 
 
Chiral azetidines constitutes an important class of N-containing four-membered 
heterocycles incorporated in natural products, and recently also applied as a chiral ligand for  
 
 
Figure 1.- Presence of azetidine in biologically important compounds. 
 
asymmetric transformations.[1] The general approach for their preparation normally involves a 
large sequence of linear steps delivering the heterocycles in low yields.[2] More efficient route  
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Scheme 1.- Formal [2+2] cycloaddition of aldimines with allenoates. 
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to azetidines is through [2+2] cycloaddition reaction.[3] In an attempt to extend the scope of  
aza-Morita-Baylis-Hillman reaction to a different α,β-unsaturated enones, Shi and co-workers  
2
E-
2
 
Scheme 2.- Achiral formal [2+2] cycloaddition of ketimines with allenoates. 
identified generation of azetidines in the reaction with aldimines and 2,3-butadienote by   
using DABCO as catalyst via formal [2+2] cycloaddition process (Scheme 1a).[4] The 
corresponding  asymmetric protocol was  later developed by Masson and Zhu by using an  
 
Table 1.- Catalyst screening for formal [2+2] cycloaddition of ketimines with allenoates. 
 
Entry Organocatalyst Solvent T (°C) t (h) Yield %[a] ee % 
1 DABCO THF 25 96 43 -- 
2 DMAP THF 25 96 20 -- 
3 DBU  THF 25 96 0 -- 
4 β-ICD THF 25 24 42 80 
5 β-ICD 1,4-dioxane 25 24 58 82 
6 β-ICD DCM 25 24 36 66 
7 β-ICD toluene 25 24 28 80 
8 β-ICD THF 0 24 45 84 
9 β-ICD THF/1,4-dioxane (1:1) 0 24 49 (69)b 89(87)b 
10 β-ICD THF/1,4-dioxane (1:2) -5 48 82b 87b 
11 36 THF/1,4-dioxane (1:1) 0 24 10(trace)c 65(nd)c 
12 37 THF/1,4-dioxane (1:1) 0 24 23 59 
13 cinchonine, 
quinidine or 8 
THF/1,4-dioxane (1:1) 0 24 0 -- 
[a] Determined by 1H-NMR. [b] MS 4Å was added. [c] 20 mol% of 2-naphthol was added. nd: Not determined. 
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alkaloid-type tertiary amine organocatalyst (Scheme 1b).[5] Is important to notice that in the 
case of Masson and Zhu report, they observed the competitive formation of aza-MBH-adduct 
30 as minor byproduct, affecting the yield of the desired azetidine. In 2012, the group of Ye 
has reported the achiral synthesis of azetidines bearing a tetrasubstituted carbon center via 
formal [2+2] cycloaddition of cyclic ketimines (Scheme 2).[6] Interestingly, although they 
tried to develop the enantioselective process, they were not able to observe any formation of  
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Scheme 3.- Substrate scope catalyzed of formal [2+2] cycloaddition catalyzed by β-ICD. 
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azetidine when using chiral organocatalysts. Interested in establish an enantioselective 
method, reaction using acyclic ketimine 12a was explored. Among the achiral organocatalyst 
tested, DABCO was superior delivering azetidine in 43% yield (entries 1-3). Next, various 
chiral amine catalyst were applied. β-Isocupreidine (β-ICD), acid-base organocatalyst known 
to mediate MBH-processes,[7] afforded 34a in moderate yield with 80% ee (entry 4). Using 
1,4-dioxane or lowering the reaction temperature (entries 5, 8) had a positive effects on the 
chemical yield and enantioselectivities. Furthermore, the mixed solvent of THF/1,4-dioxane 
(1:1 ratio) achieved good outcomes in terms of enantioselectivity (entry 9). Applying 
amide-type analogous β-ICD 36 (in presence or absence of naphthol),[8] cinchonine, 
organocatalyst 37, quinine or organocatalyst 8,[9] exhibited low or no activity (entries 11-13). 
Notably, neither formation of aza-MBH adduct 35a nor the Z-configuration of azetidine 34a 
was observed in any reaction; however, α-ketoester was formed due to partial hydrolysis of 
ketimine. To suppress the decomposition, molecular sieves (MS 4A) were added to reaction. 
The addition of MS 4A improved the chemical yield maintaining high enantioselectivity 
(entry 9). Further optimization allowed the optimal condition with a mixed solvent 
THF/1,4-dioxane (1:2) at -5 °C in the presence of MS 3A (Scheme 3, 34a). Under the optimal 
conditions, highly E-selective and (R)-configured azetidines 34 were obtained in good to 
excellent yields with high enantioselectivities (83-92% ee) irrespective of the electronic 
nature of substituent groups on the aromatic ring. Single recrystallization of azetidine 34g 
afforded optically pure azetidine (> 99% ee). Using benzyl-ester allenoate (CO2Bn) delivers 
azetidine in 71% chemical yield and 90% ee, however, it came accompanied by formation of 
byproduct 38 in 18% yield. Absolute configuration was indirectly deducted by comparison 
with a literature reported compound (see supplementary section). 
        
 
    
 
Scheme 4.- Synthetic transformations of azetidine (R)-34. 
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 To demonstrate the synthetic utility of highly functionalized azetidines 34, various 
transformations were performed (Scheme 4). Allyl alcohol 39 was obtained by DIBAL-H 
reduction of 34d. β-Lactam 40 was synthesized in 96% yield by oxidation with O3. 
Subsequently, treatment of lactam 40 with Mg/MeOH cleaved the amide bond to provide 
acyclic α,α-disubstituted amino acid derivative 41 in good yield. Finally, 34e could react with 
phenylboronic acid via Suzuki-Miyaura cross-coupling to quantitatively give biphenyl 
compound 42. 
. 
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Scheme 5.- Our proposed reaction mechanism. 
 
 
Scheme 6.- Formal [2+2] cycloaddition of 12d with 26a using methyl capped β-ICD. 
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The proposed mechanism of [2+2] cycloaddition is shown in scheme 5. Addition of 
β-ICD to allenoate 26 affords the resonance-stabilized zwitterionic intermediate I, which 
could react with ketimine 12 according to two different pathways. Addition of the 
γ-carbanion to 12 would yield intermediate II, which upon 4-exo-trig cyclization would give 
intermediate III. To avoid steric interactions between the aryl substituent of ketimine and the 
quinoline backbone in the catalyst, the reaction using β-ICD would favor product with 
(R)-configuration. Finally, azetidine 34 is formed upon fragmentation of III, with concurrent 
regeneration of catalyst. In contrast, formation of aza-MBH compound 35 through the 
addition of the α-carbanion Ib to ketimine is not supported probably because of the steric 
hindrance in the ketimine. To gain insights into the enantioselective induction step, an 
additional experiment with modified catalyst was performed (Scheme 6). By using a methyl 
capped β-ICD organocatalyst resulted in low activity and low enantioselectivity, implying the 
important role of hydroxyl unit in the catalyst. Based on this result, we hypothesized that the 
oxygen on the sulfonyl group in the ketimine would be activated by OH group in β-ICD 
through hydrogen bond. Although, coordination with the oxygen in the carbonyl group on the 
ketimine cannot be ruled out. Further calculations studies using computational chemistry are 
necessary to better understand the transition state involved in the present mechanism.   
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Chapter 4 
 Formal [4+2] cycloaddition reaction of ketimines 
 
 Functionalized tetrahydropyridines represent an important motif largely found in 
many pharmaceuticals and  natural  products (Figure 1).[1] Among the different approaches  
 
Figure 1.- Biologically active tetrahydropyridine-containing compounds. 
 
reported in literature, [4+2] cycloaddition reaction constitutes the more straightforward 
method for their construction.[2] Since the  pioneering report in 2003 by Prof. Kwon and her 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.- Formal [4+2] cycloaddition of aldimines with allenoates. 
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co-workers on the preparation of tetrahydropyridine from aldimines and allenoates promoted 
by PBu3, Lewis base (LB) organocatalysis was recognized as an important route to synthesize 
this family of heterocycles (Scheme 1a).[3] The corresponding asymmetric transformation was 
later  developed by using a  binaphthyl-based C2-symmetric mono-phosphine and an amino  
 
 
Scheme 2.- Achiral formal [4+2] cycloaddition of ketimines with allenoates. 
acid-based bifunctional phosphine by Fu and by Zhao’s groups, respectively (Scheme 1b).[4] 
However, despite of the importance of tetrahydropyridines bearing a tetrasubstituted 
stereogenic carbon center in areas such as medicinal chemistry,[1] the asymmetric preparation 
of these systems remained elusive for long time. In 2012, Ye’s group described the synthesis  
 
Table 1.- Catalyst screening for formal [4+2] cycloaddition of ketimines with allenoates. 
Entry Chiral phosphine t (h) T (°C) Ratio 47:47’[a] Total yield[b] ee of 47 (%) ee of 47’ (%) 
1 (S)-BINAP 24 reflux -- no reaction -- -- 
2 (R)-QUINAP 24 reflux -- no reaction -- -- 
3 (R)-MeO-MOP, 
(R)-7, (S)-9 
24 reflux -- no reaction -- -- 
4 (R, R)-DIOP 24 reflux 1.3:1 35 55 11 
5 (S, R)-BPPFA 24 reflux 1:2.1 34 70 6 
6 (S, R)-BPPFOH 24 reflux 1:2.8 23 84 9 
7 (R)-SITCP 3 25 5:1 83 86 8 
8[c] (R)-SITCP 3 25 > 20:1 88 90 -- 
9[c] (S)-48 3 25 > 20:1 81 80 -- 
[a] Determined by 1H-NMR. [b] 1H-NMR (1,3,5-trimethoxybenzene as internal standard). [c] MS 4Å was added. 
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of tetrahydropyridines bearing a tetrasubstituted carbon center by using a saccharin-derived 
cyclic ketimines and catalyzed by an electron-deficient triaryl phosphine (Scheme 2).[5] They 
were able to obtain in moderate to excellent selectivity the thermodynamically favored 
β’-adduct in good yields (55-75%). Towards the development of an enantioselective process, 
formal [4+2] cycloaddition of ketimines was initially explored with different phosphines 
(Table 1). Triaryl phosphines (BINAP, QUINAP, (R)-Me-MOP, catalyst (R)-7 and (S)-9) 
were found to be inactive in the present transformation (entries 1-3). Shifting to a 
monomethyl or/and ferrocenyl-containing phosphines, a stimulating enantioselectivity value 
was observed (55-84% ee), although in low yield and low regioselectivity (entries 4-6). 
Interestingly, spiro-type organocatalyst (R)-SITCP[6-8] was found to promote with high 
enantioselectivity and modest regioselectivity the formal [4+2] cycloaddition reaction (entry 
7). Further optimization revealed the use of MS 4 Å to have a markedly effect as additive to 
deliver exclusively the formation of the γ-adduct in 88% yield and 90% ee (entry 8). 
Evaluation of the corresponding binaphthyl-type monophosphine provided the desired 
compound in similar regioselectivity but slightly lower yield and enantioselectivity (entry 9). 
Decreasing the catalyst loading affected both regioselectivity and enantioselectivity 
(supplementary section). The substrate scope was then evaluated under the obtained 
optimized reaction conditions (Scheme 3). High regioselectivity and high enantioselectivity 
was observed independently of the electronic nature of the substituted groups on the aromatic 
ring (entries 47a-h). Bulky 2-naphthyl group was also tolerated (47i). 2-pyridin ring and an 
ester group were also successfully introduced, although with lower enantioselectivity (entries 
47j and 47k). The reaction of alkyl-substituted ketimine 32l did not afford any cycloadduct; 
however it resulted in the recovery of the starting material even at increased reaction 
temperatures and prolonged reaction  times. The absolute configuration was determined by  
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[a] Stirred for 8 hours. 
Scheme 3.- Substrate scope catalyzed by (R)-SITCP.  
 
single X-ray crystallographic analysis of tetrahydropyridine 47c (Figure 2).[9] Absolute 
configuration of 47a-b and 47d-k was tentatively assigned by comparison of their optical 
rotation. 
 
 Based on the observed results and related literature reports,[3,4,5b] the reaction 
mechanism is believed to proceed as illustrated in Scheme 4. The addition of phosphine 
organocatalyst to α-methyl allenoate 43 triggers the generation of reactive zwitterionic 
species I. Electronrich and nucleophilic monoaryl-phosphine leads to formation of kinetically  
27 
 
 
 
 
 
Figure 2.- Drawing ORTEP of tetrahydropyridine 47c. 
 
favored γ-addition to ketimine 32 through intermediate Ia. Once intermediate II is generated, 
intramolecual cyclization affords the tetrahydropyridine 47 with concomitant regeneration of 
the catalyst. To avoid steric interactions between the R substituent in the ketimines and 
phenyl substituent on the catalyst, the present system using (R)-SITCP favor the formation of 
(R)-tetrahydropyridine 47a-i or (S)-47j-k. Proton source from H2O or 2-naphthol[10] could 
assist the generation of Ib, and consequently the formation of β’-tetrahydropyridine 47’.  
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Scheme 4.- Proposed reaction mechanism. 
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2013, 52, 2525; b) D. Wang, Y. Wei, M. Shi, Chem. Commun. 2012, 48, 2764; c) Q.-G. Wang, S.-F. 
Zhu, L.-W. Ye, C.-Y. Zhou, X.-L. Sun, Y. Tang, Q.-L. Zhou, Adv. Synth. Catal. 2010, 352, 1914; d) 
Y. K. Chung, G. C. Fu Angew. Chem. Int. Ed. 2009, 48, 2225. 
[9] CCDC No. 964567 ((R)-47c) contains the supplementary crystallographic data. This data can be 
obtained free of charge from the Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
[10] An addition of Brønsted acid such as 2-naphthol (20 mol%) led to drastically dropping of 
reaction rate and stereoselectivities; after 24 h, 50% total yield of products 47a and 47a′ (47a:47a′ = 
1:1.2) were obtained in 19% ee for 47a and 11% ee for 47a′, respectively. 
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Chapter 5 
 Synthesis of cyclobutane by formal [2+2] cycloaddition  
reaction of tetrasubstituted alkenes 
 
2
2
2
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Figure 1.- Cyclobutane-containing biologically active compounds. 
 
Four-membered rings are important structural motifs frequently present in bioactive 
natural products and pharmaceutical agents.[1] This interesting constraint ring has also been  
recently studied in the field of catalysis. Murakami[2] and Cramer[3] have presented a variety  
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Scheme 1.- Organocatalytic formal [2+2] cycloaddition reaction. 
30 
of synthetic applications by making use of the high reactivity on the C-C bond. However, 
most of the existing methods only give access to racemic cyclobutanes, and only a few 
reports of asymmetric metal-catalyzed reactions have been documented.[4] Organocatalysis, 
particularly aminocatalysis, has shown their potential by a couple of reports on the 
asymmetric synthesis. Ishihara and co-workers reported an enantioselective [2+2] 
cycloaddition of unactivated alkenes 50 and α-acyloxyacroleins 49 under iminium catalysis 
(Scheme 1a).[5] Blackmond,[6a,b] and Seebach, Hayashi and their co-workers,[6c] contributed on 
the study of Michael addition of aldehydes and nitroalkenes for the identification by NMR of 
the formation of an unexpected cyclobutane intermediate derived from a formal [2+2] 
cycloaddition. Inspired by these precedents reports, Jørgensen and co-workers[7] designed a 
novel bifunctional catalyst 55 for the remote activation of α,β-unsaturated aldehydes 52 and 
nitroalkenes 53 under the concept of dienamine activation (Scheme 1b).  
 
Table 1.- Catalyst screening for formal [2+2] cycloaddition reaction of 56a with 26a. 
 
 
Entry Organocatalyst Yield % dr %[a] ee % 
1 DMAP 0 -- -- 
2 DABCO 65 > 20:1 -- 
3 DBU  0 -- -- 
4 TMG 0 -- -- 
5[b] β-ICD 0 -- -- 
6[b] cinchonine 0 -- -- 
7[b] quinidine 0 -- -- 
8[b] (S)-58 0 -- -- 
[a] Determined by 1H-NMR. [b] Stirred for 24 h under relux. TMG = 1,1,3,3-tetramethylguanidine. 
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 With the aim of expanding the allenoate chemistry by using organocatalysis,[8] 
enantioselective synthesis of cyclobutane was studied. Formal [2+2] cycloaddition was 
explored with an electron-deficient tetrasubstituted alkene 56a in presence of different 
organocatalysts (Table 1). The initial exploration of achiral Lewis base shown DMAP, DBU, 
and TMG to be inactive on the cycloaddition (entries 1,3,4). Satisfyingly, the reaction in 
presence of DABCO afforded formation of the 4-member ring system in moderate yield and 
high diastereoselectivity (entry 2). Next, chiral organocatalysts were evaluated. Surprisingly, 
reaction in presence of alkaloid-type, including β-ICD, or BINOL-based organocatalysts, did 
not promote formal [2+2] cycloaddition even under reflux reaction conditions (entries 5-8), 
probably due to a steric hindrance.     
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Scheme 2.- Thiourea co-catalyst asymmetric cyclobutane synthesis. 
 
 Asymmetric induction by using achiral Lewis base and co-catalyst chiral thiourea 
has been reported by different groups.[9] Formal [2+2] cycloaddition was thus explored in a 
co-catalytic system of DABCO and chiral thioureas (Scheme 2). Bis-thiourea and thiourea 
32 
59-61 delivers formation of cyclobutane in similar moderate yields, however enantioselective 
induction was not observed, affording compound 57 in racemic form. Developed by our 
group, a more rigid SPIRO-derived bisthiourea 62 showed moderated enantioselective 
induction on cyclobutane synthesis, up to 40% ee.  
 
 With the promising results observed by using co-catalyzed DABCO and spiro-based 
bisthiourea 62, we are currently trying to improve the above results. It is believed that a 
modification on the spiro compound, perhaps introducing a bulky substituent, may increase 
the enantioselectivity on the cyclobutane compound. 
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Supplementary section 
 
Chapter 2. 
Preparation of ketimines 12 
A solution of the corresponding keto ester (1.25 eq), p-toluenesulfonamide (1.0 eq.), and 
triethylamine (1.0 eq) in CH2Cl2 was cooled to 0 oC. To this mixture was added a solution of TiCl4 
(1.0 eq.) in CH2Cl2 under N2. The mixture was stirred at 0 ºC for 30 min. and then warmed to ambient 
temperature and stirred for 1 h. The mixture was then quenched with sat. NaHCO3 and extracted three 
times with DCM. The combined organic phases were washed with brine, dried over Na2SO4, and 
concentrated. The resulting residue was purified by SiO2 column chromatography (15% 
EtOAc/hexane) or GPC (CHCl3 only) to afford 12.  
 
REPRESENTATIVE DATA 
 
 
12c: yellow oil (58%); 1H-NMR (CDCl3) δ 7.91 (d, 2H, J = 8.2 Hz), 7.39 (d, 
1H, J = 1.4 Hz), 7.35-7.32 (m, 3H), 6.83 (d, 1H, J = 8.2 Hz), 6.06 (s, 2H), 
4.55 (q, 2H, J = 7.3 Hz), 2.43 (s, 3H), 1.47 (t, 3H, J = 7.3 Hz); 13C-NMR 
(CDCl3) δ 166.2, 164.9, 153.7, 148.6, 144.5, 136.0, 129.7, 127.8, 127.9, 
125.8, 108.5, 102.4, 63.2, 21.7, 14.0; HRMS (ESI) calcd for C18H17NO6SNa 
398.0674 [(M+Na)+], found m/z = 398.0670; IR (KBr): ν 3086, 2987, 1743, 1600, 1318, 1248, 1155 
cm-1. 
 
12d: yellow solid (65%); 1H-NMR (CDCl3) δ 7.90 (d, 2H, J = 8.2 Hz), 7.77 (d, 
2H, J = 7.3 Hz), 7.57 (t, 1H, J = 7.3 Hz), 7.52 (d, 1H, J = 2.3 Hz), 7.50 (d, 1H, 
J = 1.4 Hz), 7.44-7.37 (m, 5H), 7.31 (d, 2H, J = 8.2 Hz), 5.52 (s, 2H), 2.43 (s, 
3H); 13C-NMR (CDCl3) δ 166.8, 164.7, 144.8, 135.5, 134.8, 134.2, 131.3, 129.9, 
129.7, 129.1, 129.0, 128.9, 128.7, 128.2, 68.9, 21.7; HRMS (ESI) calcd for 
C22H19NO4SNa, m/z = 416.0932 [(M+Na)+], found m/z = 416.0927; IR (KBr): ν 3061, 2952, 1741, 
1594, 1332, 1158 cm-1. 
 
 
 
 
 
 
 
35 
General procedure for enantioselective aza-MBH reaction of 11 and 12. 
To a solution of organocatalyst (Sp)-15 (10-20 mol%), N-tosylketimine 12 (0.040 mmol) in MTBE 
(0.2 mL) was added enone (0.12 mmol, 3.0 eq.). The reaction mixture was stirred at 5-10°C, and was 
stirred until the reaction reached completion determined by TLC analysis. After purification via 
column chromatography, product 13 was obtained. 
 
13c: pale yellow oil (86%); 1H-NMR (CDCl3) δ 7.50 (d, 2H, J = 8.2 Hz), 7.28 
(dd, 1H, J = 2.3, 1.8 Hz), 7.20 (d, 2H, J = 7.8 Hz), 7.15 (d, 1H, J = 1.8 Hz), 
6.79 (d, 1H, J = 8.2 Hz), 6.45 (s, 1H), 6.41 (s, 1H), 6.33 (s, 1H), 5.97 (d, 1H, J 
= 1.8 Hz), 5.96 (d, 1H,  J = 1.4 Hz), 4.07 (qd, 1H, J = 12.4, 7.3 Hz), 4.04 (qd, 
1H, J = 12.4, 7.3 Hz), 2.39 (s, 3H), 1.74 (s, 3H), 1.10 (t, 3H, J = 7.3 Hz); 
13C-NMR (CDCl3) δ 196.8, 170.4, 147.6, 147.2, 144.2, 142.9, 138.5, 135.6, 
130.5, 129.0, 127.8, 122.9, 109.4, 107.4, 101.4, 67.3, 62.6, 24.6, 21.4, 13.7; 
HRMS (ESI) calcd for C22H23NO7SNa, m/z = 468.1092 [(M+Na)+], found m/z = 468.1080; 
enantiomeric excess: 41%, determined by HPLC (Chiralcel OD-H, hexane/2-propanol = 10/1, flow 
rate 1.0 ml/min, 25°C, 230 nm) minor peak: tR = 32.2 min, major peak: tR = 22.4 min; [α]21D  = +47.6 
(c 0.21, CHCl3); IR (KBr): ν 3328, 1733, 1680, 1503, 1393, 1228, 1161 cm-1. 
 
 
13d: pale yellow oil (98%); 1H-NMR (CDCl3) δ 7.73-7.71 (m, 2H), 7.50 (d, 
2H, J = 8.4 Hz), 7.35-7.33 (m, 3H), 7.27-7.26 (m, 3H), 7.20 (d, 2H, J = 8.8 
Hz), 7.07-7.05 (m, 2H), 6.53 (s, 1H), 6.39 (s, 1H), 6.28 (s, 1H), 5.00 (d, 1H, J  
= 12.4 Hz), 4.96 (d, 1H, J = 11.9 Hz), 2.39 (s, 3H), 1.70 (s, 3H); 13C-NMR 
(CDCl3) δ 197.0, 170.4, 144.1, 142.9, 138.6, 136.6, 135.7, 134.6, 129.1, 128.9, 
128.4, 128.3, 128.2, 127.8, 127.8, 68.3, 67.6, 24.5, 21.4; HRMS (APCI) calcd 
for C26H25NO5SH, m/z = 464.1531 [(M+H)+], found m/z = 464.1529; enantiomeric excess: 41%, 
determined by HPLC (Chiralpak AS-H, hexane/2-propanol = 65/35, flow rate 0.5 ml/min, 25°C, 219 
nm) minor peak: tR = 28.9 min, major peak: tR = 19.0 min; [α]21D  = +3.1 (c 3.2, CHCl3); IR (KBr): ν 
3289, 1737, 1681, 1448, 1330, 1225, 1164 cm-1. 
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Figure S3. ORTEP drawing of racemic 34e. 
 
 
 
[α]
 =	+8.5   [α]	
 =	+4.88 
Table S3. Indirect determination of absolute configuration on azetidine 34. 
 
 
Compound 100 is a reported compound: 
M. K. Ghorai and D. P. Tiwari, J. Org. Chem. 2010, 75, 6173. 
 
 
 
 
37 
General procedure for enantioselective formal [2+2] cycloaddition of ketimines with allenoates 
To a solution of β-ICD (20 mol%), N-tosylketimine 12 (0.060 mmol) and powdered molecular sieves 
3A (20 mg) in 0.3 mL of THF/1,4-dioxane mixture (1:2) at -5 °C, allenoate 26 (0.12 mmol, 3.0 equiv) 
was added under nitrogen atmosphere. The reaction mixture was stirred at -5 °C until the reaction 
reached completion determined by TLC analysis. The crude product was filtered with EtOAc in a 
short column of silica and purified via column chromatography (hexane/EtOAc) to obtain the 
corresponding compound 34. 
 
34a: pale yellow oil (82%); 1H-NMR (CDCl3) δ 7.45-7.32 (m, 7H), 7.17 (d, 
2H, J = 8.2 Hz), 5.69 (t, 1H, J = 1.8 Hz), 4.34 (qd, 1H, J = 11.0, 7.3 Hz), 
4.29 (qd, 1H, J = 11.0, 7.3 Hz), 4.14 (q, 2H, J = 7.3 Hz), 3.68 (d, 2H, J = 
1.8 Hz), 2.39 (s, 3H), 1.31 (t, 3H, J = 7.3 Hz), 1.27 (t, 3H, J = 7.3 Hz); 
13C-NMR (CDCl3) δ 169.4, 167.2, 156.2, 144.5, 135.9, 134.7, 129.4, 129.2, 
128.6, 127.5, 127.2, 93.4, 77.6, 62.6, 59.8, 41.6, 21.6, 14.4,  14.0; HRMS (ESI) calcd for 
C23H25NO6SNa, m/z = 466.1295 [(M+Na)+], found m/z = 466.1297; IR (KBr): ν 2925, 1739, 1708, 
1656, 1366, 1167, 1088 cm-1; enantiomeric excess: 87%, determined by HPLC (Chiralpak AD, 
hexane/2-propanol = 4/1, flow rate 1.0 mL/min, 25 °C, 260 nm) minor peak: tR = 11.5 min, major 
peak: tR = 25.9 min;[α]	 =	+26.0 (c 0.6, CHCl3). 
 
34d: pale yellow oil (83%); 1H-NMR (CDCl3) δ 7.41 (d, 2H, J = 8.2 Hz), 
7.38-7.29 (m, 10H), 7.13 (d, 2H, J = 8.2 Hz), 5.69 (t, 1H, J = 1.8 Hz), 5.30 
(d, 1H, J = 12.4 Hz), 5.25 (d, 1H, J = 12.4 Hz), 4.13 (q, 2H, J = 7.3 Hz), 
3.69 (dd, 1H, J = 16.5, 1.8 Hz), 3.64 (dd, 1H, J = 16.5, 1.8 Hz), 2.38 (s, 
3H), 1.26 (t, 3H, J = 7.3 Hz); 13C-NMR (CDCl3) δ 169.3, 167.1, 156.0, 
144.5, 135.8, 134.8, 134.6, 129.4, 129.2, 128.61, 128.58, 128.5, 128.3, 127.5, 127.2, 93.6, 77.6, 68.0, 
59.8, 41.5, 21.6, 14.4; HRMS (ESI) calcd for C24H27NO6SNa, m/z = 528.1451 [(M+Na)+], found m/z 
= 528.1451; IR (KBr): ν 2926, 1741, 1708, 1657, 1366, 1167, 1090 cm-1; enantiomeric excess: 83%, 
determined by HPLC (Chiralpak AD, hexane/2-propanol = 9/1, flow rate 1.0 mL/min, 25 °C, 260 nm) 
minor peak: tR = 26.5 min, major peak: tR = 51.3 min; [α]	
 =	+19.0 (c 0.3, CHCl3).       
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Table S1. Optimization for the enantioselective organocatalyzed formal [4+2] cyloaddition of 
ketimines. 
 
 
 
 
Entry Solvent 
T 
(°C) X Additive t (h) 
Ratio of 
47a:47a′ 
Yield of 47a 
(%) 
ee of 47a 
(%) 
1 toluene 25 20 No 24 2.2:1 47 61 
2 THF 25 20 No 24 --- 
low 
conversion 
--- 
3 t-BuOMe 25 20 No 24 --- 
low 
conversion 
--- 
4 CHCl3 25 20 No 24 3.5:1 60 73 
5 DCM 25 20 No 3 5:1 69 86 
6 DCM 35 20 No 3 10:1 79 87 
7 DCM 15 20 No 24 8.3:1 79 89 
8 DCM 25 20 MS 4A 3 >20:1 88 90 
9 DCM 25 20 
2-naphthol 
(20 mol%) 24 1:1.2 23 19 
10 DCM 25 10 MS 4A 3 14.3:1 82 84 
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General procedure for enantioselective formal [4+2] cycloaddition of 32 with 43. 
To a solution of spiro monophosphine catalyst (R)-SITCP (20 mol%), cyclic ketimine 32 (0.02g, 
0.060 mmol) and powdered molecular sieves 4A (20 mg) in 0.3 mL of anhydrous DCM at 25 °C, 
allenoate 43 (2.0 equiv) was added under nitrogen atmosphere. The reaction mixture was stirred at 25 
°C until the reaction reached completion determined by TLC analysis. The crude product was filtered 
with EtOAc through a short column of silica gel and purified via column chromatography 
(hexane/EtOAc) to obtain the corresponding compound 47. 
 
47a: 88% yield; colorless oil; 1H-NMR (CDCl3) δ 7.89-7.87 (m, 1H), 7.55-7.52 
(m, 2H), 7.40-7.31 (m, 5H), 7.21-7.19 (m, 1H), 7.10-7.07 (m, 1H), 4.56 (m, 
1H), 4.17 (qd, 1H, J = 10.1, 7.3 Hz), 4.15 (qd, 1H, J = 10.1, 7.3 Hz), 3.62-353 
(m, 1H), 3.46 (ddd, 1H, J = 18.3, 6.4, 2.3 Hz), 2.75-2.66 (m, 1H), 1.27 (t, 3H, J 
= 7.3 Hz); 13C-NMR (CDCl3) δ  164.3, 143.4, 137.8, 135.1, 133.2, 132.6, 129.3, 129.1, 128.6, 127.5, 
126.9, 123.9, 121.6, 63.4, 61.0, 35.7, 32.9, 14.1; HRMS (ESI) calcd for C20H19NO4SNa, m/z = 
392.0927 [(M+Na)+], found m/z = 392.0928; IR (KBr): ν 2982, 1710, 1658, 1492, 1295, 1256, 1175, 
738, 575 cm-1; enantiomeric excess: 90%, determined by HPLC (Chiralpak IA, hexane/2-propanol = 
4/1, flow rate 1.0 mL/min, 25 °C, 220 nm) minor peak: tR = 11.4 min, major peak: tR = 14.7 min; 
[α]
	 =	-278.7 (c 0.7, CHCl3, 90% ee). 
 
47c: 81% yield; white solid; m.p. 46-48 °C;1H-NMR (CDCl3) δ 7.90-7.88 (m, 1H), 
7.58-7.53 (m, 2H), 7.48 (d, 2H, J = 8.2 Hz), 7.25 (d, 2H, J = 8.2 Hz), 7.20-7.17 
(m, 1H), 7.08-7.06 (m, 1H), 4.56 (m, 1H), 4.20 (qd, 1H, J = 10.1, 7.3 Hz), 4.16 
(qd, 1H, J = 10.1, 7.3 Hz), 3.59-3.52 (m, 1H), 3.40 (ddd, 1H, J = 18.3, 6.4, 2.3 
Hz), 2.74-2.67 (m, 1H), 1.28 (t, 3H, J = 7.3 Hz); 13C-NMR (CDCl3) δ 164.2, 142.7, 137.0, 134.7, 
133.3, 132.7, 132.3, 129.6, 128.8, 127.7, 123.8, 122.9, 121.7, 63.0, 61.1, 35.7, 32.8, 14.1; HRMS (ESI) 
calcd for C20H18BrNO4SNa, m/z = 470.0032 [(M+Na)+], found m/z = 470.0036; IR (KBr): ν 2927, 
1714, 1660, 1446, 1291, 1257, 1170, 757, 511 cm-1; enantiomeric excess: 91%, determined by HPLC 
(Chiralpak AD-H, hexane/2-propanol = 7/1, flow rate 1.0 mL/min, 25 °C, 230 nm) minor peak: tR = 
34.4 min, major peak: tR = 39.5 min; [α]	
 =	-151.0 (c 0.5, CHCl3, 91% ee). 
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General procedure for synthesis of cyclobutane by formal [2+2] cycloaddition of 
tetrasubstituted alkenes 
To a solution of DABCO (20 mol%), tetrasubstituted alkene 56 (0.073 mmol) and chiral bisthiourea 
62 (20 mol%) in 0.4 mL of THF at -5 °C, allenoate 26a (0.146 mmol, 2.0 equiv) was added under 
nitrogen atmosphere. The reaction mixture was stirred at -5 °C until the reaction reached completion 
determined by TLC analysis. The crude product was filtered with EtOAc in a short column of silica 
and purified via column chromatography (hexane/EtOAc) to obtain the corresponding compound 57. 
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Conclusions 
 
 Several organocatalytic processes were developed. P-chirogenic organocatalyst gives 
access to multifunctional allylic amines in high enantioselectivity. Alkaloid-type tertiary 
amine β-ICD afforded four-membered nitrogen-containing azetidines in high yields and high 
enantioselectivity. A spiro type phosphine was successfully applied on the regio- and 
enantioselective synthesis of tetrahydropyridine compounds. Finally, a combination of achiral 
Lewis base and chiral bisthiourea allows access to cyclobutane in moderate enantioselectivity 
and diastereoselectivity under organocatalytic reaction conditions.   
 
 A variety of molecules were prepared in enantioselective manner by using chiral 
organocatalysis. Synthetically useful compounds bearing a tetrasubstituted stereogenic 
carbon center were in most cases applied as a chiral building blocks for further elaboration of 
important compounds such as α,α-disubstituted amino acids derivatives. 
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